ArticleScientific reports2026
Role of natural inter-individual variability in the different penetrance of congenital long QT syndromes (LQTS) types 1 and 2: an in silico approach.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Congenital Long QT Syndrome types 1 and 2 (LQT1 and LQT2) are caused bymutations in the KCNQ1 and KCNH2 genes, responsible for the IKs and IKr currents, respectively. However, the penetrance of these mutations is highly variable, since some carriers remain asymptomatic, while others exhibit severe clinical manifestations. To elucidate how physiological variability in other cardiac ionic currents may influence the arrhythmic phenotype, human ventricular action potentials were simulated in silico using the O'Hara-Rudy dynamic model implemented in the Virtual Assay software. Conductances of nine key ionic currents were randomly modified within physiologically plausible ranges and the resulting population of models was validated under stress conditions. LQT1 and LQT2 cohorts were generated by reducing IKs by 80% and IKr by 60%, respectively. These cohorts were stratified into four risk categories based on action potential duration (APD) under different conditions and the occurrence of arrhythmic events. LQT1 models demonstrated impaired adaptation to adrenergic stimulation, whereas LQT2 models showed marked APD prolongation at rest. Risk stratification revealed a higher incidence of arrhythmic events in LQT2 (7.6%) compared to LQT1 (0.55%). Regression analyses identified IKr and IK1 as protective currents, while INaL and ICaL were major contributors to APD prolongation in both types. Simulated blockade of L-type Ca²⁺ channels effectively shortened APD and reduced the proportion of high-risk models. The natural variability in ionic current profiles contributes to the phenotypic expression of LQTS and support the potential use of calcium channel blockers as therapeutic alternatives in patients unresponsive to β-blockers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.